
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1081 | 1050 | 1095 | 1222 | 1524 | 1701 |
Fund Return | 8.12% | 5.04% | 9.49% | 6.92% | 8.79% | 5.46% |
Place in category | 136 | 180 | 344 | 117 | 181 | 132 |
% in Category | 16 | 22 | 50 | 19 | 30 | 35 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BlackRock S&P 500 Index K | 17.77B | 1.43 | 12.50 | 12.94 | ||
BlackRock International Index Instl | 11.17B | 8.13 | 6.85 | 5.40 | ||
BlackRock International Index Inv A | 11.17B | 8.13 | 6.60 | 5.14 | ||
BlackRock Equity Dividend Instl | 10.11B | 6.33 | 7.78 | 9.67 | ||
BlackRock Global Allocation Inv A | 8.08B | 2.59 | 3.95 | 5.14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 209.79B | 5.17 | 4.34 | 4.95 | ||
Vanguard Total Intl Stock Index Adm | 76.18B | 5.24 | 4.42 | 5.02 | ||
Fidelity International Index Inst | 55.99B | 8.06 | 6.85 | 5.50 | ||
Fidelity Series Global ex US Index | 52.88B | 6.06 | 4.88 | 4.92 | ||
Strategic Advisers International I | 47.55B | 7.61 | 6.47 | 6.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 2.15 | 512.4 | -1.78% | |
ASML Holding | NL0010273215 | 1.87 | 674.70 | +0.01% | |
Nestle | CH0038863350 | 1.48 | 88.84 | -0.85% | |
AstraZeneca | GB0009895292 | 1.36 | 11,316.0 | -1.19% | |
SAP | DE0007164600 | 1.34 | 258.750 | +1.33% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review